Cargando…

Identification of key genes in non-alcoholic fatty liver disease progression based on bioinformatics analysis

Due to economic development and lifestyle changes, the incidence of non-alcoholic fatty liver disease (NAFLD) has gradually increased in recent years. However, the pathogenesis of NAFLD is not yet fully understood. To identify candidate genes that contribute to the development and progression of NAF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lin, Liu, Huabao, Hu, Xiaoyu, Huang, Yi, Wang, Yanan, He, Yansha, Lei, Qingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983972/ https://www.ncbi.nlm.nih.gov/pubmed/29620197 http://dx.doi.org/10.3892/mmr.2018.8852

Ejemplares similares

Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease
por: Nazari, Elham, et al.
Publicado: (2023)

Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease
por: Banasik, Karina, et al.
Publicado: (2011)

S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
por: Liu, Xiaolin, et al.
Publicado: (2015)

Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)

Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis
por: Liu, Jingqi, et al.
Publicado: (2020)

Identification of hub genes and key pathways of dietary advanced glycation end products-induced non-alcoholic fatty liver disease by bioinformatics analysis and animal experiments
por: Wang, Jiao, et al.
Publicado: (2020)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
por: Li, Lin, et al.
Publicado: (2017)

Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features via Bioinformatics Methods
por: Liu, Ziyu, et al.
Publicado: (2022)

Identification of Hub Genes and Immune Infiltration in Non-alcoholic Fatty Liver Disease -Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Liu, Xu, et al.
Publicado: (2023)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
por: Rodríguez-Lara, Avilene, et al.
Publicado: (2023)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Identification of Key Target Genes and Pathway Analysis in Nonalcoholic Fatty Liver Disease Via Integrated Bioinformatics Analysis
por: Chen, X., et al.
Publicado: (2023)

Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
por: Cao, Yang, et al.
Publicado: (2023)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
por: Teng, Yu-Xian, et al.
Publicado: (2022)

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
por: Yang, Fan, et al.
Publicado: (2023)

Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
por: Zhu, Yalan, et al.
Publicado: (2023)

Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
por: Riordan, Jesse D., et al.
Publicado: (2014)

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
por: Zhou, Jin, et al.
Publicado: (2021)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
por: Hochreuter, Mette Yde, et al.
Publicado: (2022)

Key Genes Associated with Non-Alcoholic Fatty Liver Disease and Acute Myocardial Infarction
por: Dai, Weiran, et al.
Publicado: (2020)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
por: Trovato, Guglielmo M
Publicado: (2020)

Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics
por: Chen, Yuanbin, et al.
Publicado: (2022)

Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis
por: Wu, Kejia, et al.
Publicado: (2018)

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
por: Zhang, Yali, et al.
Publicado: (2017)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease
por: Huang, Chao, et al.
Publicado: (2022)

Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects
por: Mehta, Rohini, et al.
Publicado: (2014)

Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review
por: Yaqub, Sayma, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19
por: Abolfazli, Pouria, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and non‐alcoholic fatty liver disease: new insights from bioinformatics
por: Wang, Anzhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pjdrogaln8aii9pasl1s592k6